The company that produced the first ever cannabis-derived medicine to be approved for use by the U.S. Food & Drug Administration has revealed to investors the cost of the drug: $32,500 per year. This is reportedly on the low-end of original estimates between $30,000 and $60,000. Epidiolex, made with CBD and used to treat rare…
Continue reading ›
CANNABIS BUSINESS LICENSING LEGAL SERVICES